These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9160523)

  • 1. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice.
    Kochel T; Wu SJ; Raviprakash K; Hobart P; Hoffman S; Porter K; Hayes C
    Vaccine; 1997 Apr; 15(5):547-52. PubMed ID: 9160523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel AAV-based genetic vaccines encoding truncated dengue virus envelope proteins elicit humoral immune responses in mice.
    Li X; Cao H; Wang Q; Di B; Wang M; Lu J; Pan L; Yang L; Mei M; Pan X; Li G; Wang L
    Microbes Infect; 2012 Sep; 14(11):1000-7. PubMed ID: 22626929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.
    Raviprakash K; Kochel TJ; Ewing D; Simmons M; Phillips I; Hayes CG; Porter KR
    Vaccine; 2000 May; 18(22):2426-34. PubMed ID: 10738100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.
    Feighny R; Burrous J; Putnak R
    Am J Trop Med Hyg; 1994 Mar; 50(3):322-8. PubMed ID: 8147490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
    Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
    Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of neutralizing antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors.
    Khanam S; Khanna N; Swaminathan S
    Vaccine; 2006 Oct; 24(42-43):6513-25. PubMed ID: 16860446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
    Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
    Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetravalent neutralizing antibody response against four dengue serotypes by a single chimeric dengue envelope antigen.
    Apt D; Raviprakash K; Brinkman A; Semyonov A; Yang S; Skinner C; Diehl L; Lyons R; Porter K; Punnonen J
    Vaccine; 2006 Jan; 24(3):335-44. PubMed ID: 16125280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.
    Raviprakash K; Marques E; Ewing D; Lu Y; Phillips I; Porter KR; Kochel TJ; August TJ; Hayes CG; Murphy GS
    Virology; 2001 Nov; 290(1):74-82. PubMed ID: 11883007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tetravalent protective immunity against four dengue serotypes by the tandem domain III of the envelope protein.
    Chen S; Yu M; Jiang T; Deng Y; Qin C; Qin E
    DNA Cell Biol; 2007 Jun; 26(6):361-7. PubMed ID: 17570760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge.
    Putnak R; Feighny R; Burrous J; Cochran M; Hackett C; Smith G; Hoke C
    Am J Trop Med Hyg; 1991 Aug; 45(2):159-67. PubMed ID: 1877710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
    Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
    Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the envelope antigen of dengue virus in vaccine strains of Salmonella.
    Cohen S; Powell CJ; Dubois DR; Hartman A; Summers PL; Eckels KH
    Res Microbiol; 1990; 141(7-8):855-8. PubMed ID: 2101475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus.
    Chang GJ; Hunt AR; Holmes DA; Springfield T; Chiueh TS; Roehrig JT; Gubler DJ
    Virology; 2003 Feb; 306(1):170-80. PubMed ID: 12620809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys.
    Blair PJ; Kochel TJ; Raviprakash K; Guevara C; Salazar M; Wu SJ; Olson JG; Porter KR
    Vaccine; 2006 Feb; 24(9):1427-32. PubMed ID: 16214271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice.
    Ocazionez Jimenez R; Lopes da Fonseca BA
    Vaccine; 2000 Nov; 19(6):648-54. PubMed ID: 11090717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains.
    Lim CS; Chua JJ; Wilkerson J; Chow VT
    Viral Immunol; 2006; 19(1):33-41. PubMed ID: 16553548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.